Azienda Ospedaliera Universitaria Delle Marche

Ancona 60020

1 studies enrolling now · 1 studies all time

What they study most

Relapsed/Refractory Multiple Myeloma

Studies at this site

• A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma — Recruiting now